The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 study of casdozokitug, an IL-27 targeting antibody, in combination with toripalimab plus bevacizumab in patients with unresectable and/or locally advanced or metastatic hepatocellular carcinoma.
 
Daneng Li
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Boehringer Ingelheim; Coherus Biosciences; Eisai; Exelixis; Genentech; Jazz Pharmaceuticals; Merck; Merus; Sumitomo Pharma Oncology; TransThera Biosciences; TriSalus Life Sciences
Research Funding - AstraZeneca (Inst)
 
Neal Chawla
No Relationships to Disclose
 
Andrea Teague
No Relationships to Disclose
 
Koho Iizuka
Employment - Coherus BioSciences; Janux Therapeutics
 
Hong Tang
Stock and Other Ownership Interests - Coherus Biosciences
 
Varun Kapoor
Employment - Coherus BioSciences
Stock and Other Ownership Interests - Coherus BioSciences
Patents, Royalties, Other Intellectual Property - Coherus BioSciences
Travel, Accommodations, Expenses - Coherus BioSciences
 
Eric Cheung
No Relationships to Disclose